An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat

No abstract is available for this paper.

• Publication year

  1995

• Venue

  British Journal of Pharmacology

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1995.tb15030.xPMID 7582550PMCID PMC1908800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes

  1994cited by this paper
• A novel inhibitory prostanoid receptor in piglet saphenous vein.

  1994cited by this paper
• Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus.

  1994cited by this paper
• Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex.

  1994cited by this paper
• International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

  1994cited by this paper
• Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity

  1993cited by this paper
• Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist.

  1993cited by this paper
• AH13205, a selective prostanoid EP2-receptor agonist

  1993cited by this paper
• Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.

  1992cited by this paper
• Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.

  1992cited by this paper
• Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethosone, isoproterenol, or prostaglandin E2 either alone or in combination

  1992cited by this paper
• Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum

  1992cited by this paper
• Investigation of the prostaglandin E (EP‐) receptor subtype mediating relaxation of the rabbit jugular vein

  1992cited by this paper
• Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

  1991cited by this paper
• Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected.

  1991cited by this paper
• Characterization of the 3',5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells.

  1991cited by this paper
• Delineation of the mechanism of inhibition of human T cell activation by PGE2.

  1990cited by this paper
• Effects of modulators of adenylyl cyclase on interleukin-2 production, cytosolic Ca2+ elevation, and K+ channel activity in Jurkat T cells.

  1990cited by this paper
• Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.

  1990cited by this paper
• Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells

  1988cited by this paper
• Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum‐Schild equations

  1988cited by this paper
• Lymphocyte hormone receptors.

  1987cited by this paper
• Regulation of interleukin 2 synthesis by cAMP in human T cells.

  1987cited by this paper
• Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979

  1986cited by this paper
• Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

  1985cited by this paper
• Prostaglandin E2 Receptors on Human Peripheral Blood Monocytes

  1985cited by this paper
• Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.

  1985cited by this paper
• Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

  1983cited by this paper
• Regulation of the immune response by prostaglandins

  1983cited by this paper
• Studies on the characterisation of prostanoid receptors: a proposed classification.

  1982cited by this paper
• High-affinity binding sites for prostaglandin E on human lymphocytes.

  1979cited by this paper
• Suppression of in vivo and in vitro alloimmunity by prostaglandins.

  1977cited by this paper
• Prolongation of murine skin allografts by prostaglandin E1.

  1977cited by this paper
• Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

  1975cited by this paper
• Effect of prostaglandin E 1 on adjuvant arthritis.

  1971cited by this paper
• Effect of Prostaglandin E1 on Adjuvant Arthritis

  1971cited by this paper

• Emerging Roles of Prostaglandins in HIV-1 Transcription

  2018cites this paper
• Motility of Colorectal Carcinoma Cells Increases Growth and 2 Prostaglandin E TRANSDUCTION: MECHANISMS OF SIGNAL

  2015cites this paper
• Emerging Roles of Prostaglandins in HIV-1 Transcription

  2011cites this paper
• Prostaglandin E2 EP receptors as therapeutic targets in breast cancer

  2011cites this paper
• Anti-inflammatory constituents of the red alga Gracilaria verrucosa and their synthetic analogues.

  2008cites this paper
• EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway.

  2007cites this paper
• Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages.

  2005cites this paper
• Functional pharmacology of human prostanoid EP2 and EP4 receptors.

  2004cites this paper
• Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor.

  2003cites this paper
• Cyclooxygenases and prostaglandins: shaping up the immune response.

  2002cites this paper
• Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.

  2002cites this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cites this paper
• Functional Pharmacological Evidence for EP2 and EP4 Prostanoid Receptors in Immortalized Human Trabecular Meshwork and Non-Pigmented Ciliary Epithelial Cells

  2001cites this paper
• Prostaglandin E2 increases cyclic AMP and inhibits endothelin‐1 production/secretion by guinea‐pig tracheal epithelial cells through EP4 receptors

  2001influential citation
• Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.

  2001cites this paper
• Prostaglandin E Receptor Subtypes in Cultured Rat Microglia and Their Role in Reducing Lipopolysaccharide‐Induced Interleukin‐1 β Production

  1999cites this paper
• Inhibitory prostanoid EP receptors in human non-pregnant myometrium.

  1999cites this paper
• Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor.

  1999cites this paper
• Prostaglandin E2 stimulates rat and human colonic mucin exocytosis via the EP4 receptor

  1999cites this paper
• Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.

  1998cites this paper
• Prostaglandin E2 Up-regulates HIV-1 Long Terminal Repeat-driven Gene Activity in T Cells via NF-κB-dependent and -Independent Signaling Pathways*

  1998cites this paper
• Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation

  1997cites this paper
• Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells.

  1997cites this paper
• COX-2 inhibitors at the 8th International Conference of the Inflammation Research Association.

  1997cites this paper
• Prostaglandin receptors of the EP2 and EP4 subtypes regulate B lymphocyte activation and differentiation to IgE-secreting cells.

  1997cites this paper
• The immunomodulatory actions of E-type prostaglandins.

  1997cites this paper
• Exclusive expression of the Gs‐linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM‐3 cells and coexpression of subtype 4 and 2 mRNA in U‐937 cells

  1996cites this paper
• Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture

  1996cites this paper